Remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in hospitalized adult and pediatric patients (aged ≥12 years and weighing ≥40 kg).

For which COVID-19 patients has been approved Remdesivir?

On October 22, 2020, the FDA approved the antiviral drug Veklury (remdesivir) for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

Is Redemsvir a drug for treating COVID-19?

Remdesivir is an FDA-approved (and sold under the brand name Veklury) intravenous antiviral drug for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

How is remdesivir being administered to patients with COVID-19?

Remdesivir comes as a solution (liquid) and as a powder to be mixed with liquid and infused (injected slowly) into a vein over 30 to 120 minutes by a doctor or nurse in a hospital. It is usually given once daily for 5 to 10 days.

What side effects can Remdesivir cause?

• nausea
• pain, bleeding, bruising of the skin, soreness, or swelling near the place where the medication was injected

Severe illness after vaccination

27 related questions found

Is Remdesivir used in treating COVID-19?

Conclusions: Remdesivir can help improve the clinical outcome of hospitalized patients with COVID-19 and a 5 day regimen, instead of a 10 day regimen, may be sufficient for treatment. Moreover, remdesivir appears as tolerable as other comparators or placebo.

What are the common side effects of the COVID-19 vaccine?

The most commonly reported side effects were pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, and fever.

Is Veklury (remdesivir) approved by the FDA to treat COVID-19?

On October 22, 2020, FDA approved Veklury (remdesivir) for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring
hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care.

Has the FDA approved remdesivir to treat COVID-19?

The FDA has approved an antiviral drug called remdesivir to treat COVID-19 in adults and children who are age 12 and older. Remdesivir may be prescribed for people who are hospitalized with COVID-19. It's given through a needle in the skin (intravenously).

What drug is used for the treatment of a hospitalized COVID-19 patient?

Your doctors may give you an antiviral medicine called remdesivir (Veklury). Remdesivir is the first drug approved by the FDA for treatment of hospitalized COVID patients over the age of 12. Research shows that some patients recover faster after taking it.

What is Remdesivir?

Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.

Is Remdesivir approved in Europe for treatment of COVID-19?

Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but no invasive ventilation.

Are there any FDA-approved drugs for COVID-19?

Yes, the FDA has approved Veklury (remdesivir) for certain COVID-19 patients.

Is remdesivir approved for use in adults and children at least 12 years old to treat COVID-19?

Remdesivir is used to treat people with coronavirus disease 2019 (COVID-19) who are in a hospital.
Remdesivir is approved for use in adults and children at least 12 years old who weigh at least 88 pounds (40 kilograms).

What is the Emergency Use Authorization (EUA) for remdesivir?

The emergency use authorization allows for remdesivir to be distributed in the U.S. and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.

Who should not get the Moderna COVID-19 vaccine?

If you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction, even if it was not severe, to any ingredient in an mRNA COVID-19 vaccine (such as polyethylene glycol), you should not get an mRNA COVID-19 vaccine.

What is Banlanivimab, one of the antibody drug that is approved to treat COVID-19?

Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful antigens such as viruses. Bamlanivimab is a monoclonal antibody that is specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.

Does dexamethasone work against COVID-19?

Dexamethasone is a corticosteroid used in a wide range of conditions for its anti-inflammatory and immunosuppressant effects.

It was tested in hospitalized patients with COVID-19 in the United Kingdom’s national clinical trial RECOVERY and was found to have benefits for critically ill patients.

Is the monoclonal antibody Actemra (tocilizumab) FDA approved for the treatment of COVID-19?

No. Actemra (tocilizumab) is not approved as a treatment for COVID-19.

Is AstraZeneca COVID-19 vaccine approved by the FDA?

The AstraZeneca vaccine is not authorized for use in the U.S., but FDA understands that these AstraZeneca lots, or vaccine made from the lots, will now be exported for use.

What are the common side effects of the Pfizer-BioNtech COVID-19 vaccine?

The most commonly reported side effects were pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, and fever. Side effects typically started within two days of vaccination and resolved 1-2 day later.

Is it normal to have side effects after second COVID-19 vaccine?

Side effects after your second shot may be more intense than the ones you experienced after your first shot. These side effects are normal signs that your body is building protection and should go away within a few days.

Are there any long term effects of COVID-19 vaccine?

Serious side effects that could cause a long-term health problem are extremely unlikely following any vaccination, including COVID-19 vaccination. Vaccine monitoring has historically shown that side effects generally happen within six weeks of receiving a vaccine dose.

What methods do we currently have to treat COVID-19?

Current clinical management of COVID-19 includes infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated. The U.S. Food and Drug Administration (FDA) has approved one drug, remdesivir (Veklury), for the treatment of COVID-19 in certain situations.

Who might benefit from dexamethasone if they have COVID-19?

Dexamethasone is a corticosteroid used in a wide range of conditions for its anti-inflammatory and immunosuppressant effects.

It was tested in hospitalized patients with COVID-19 in the United Kingdom’s national clinical trial RECOVERY and was found to have benefits for critically ill patients.